Last reviewed · How we verify
Inoculation in vastus lateralis muscle — Competitive Intelligence Brief
marketed
Immunology
Biologic
Live · refreshed every 30 min
Target snapshot
Inoculation in vastus lateralis muscle (Inoculation in vastus lateralis muscle) — Beijing Center for Disease Control and Prevention. This is an intramuscular injection administered to the vastus lateralis muscle, likely a vaccine formulation developed by Beijing CDC.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Inoculation in vastus lateralis muscle TARGET | Inoculation in vastus lateralis muscle | Beijing Center for Disease Control and Prevention | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Inoculation in vastus lateralis muscle CI watch — RSS
- Inoculation in vastus lateralis muscle CI watch — Atom
- Inoculation in vastus lateralis muscle CI watch — JSON
- Inoculation in vastus lateralis muscle alone — RSS
Cite this brief
Drug Landscape (2026). Inoculation in vastus lateralis muscle — Competitive Intelligence Brief. https://druglandscape.com/ci/inoculation-in-vastus-lateralis-muscle. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab